Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $57.88M | $36.27M | +59.55% |
Operating Income | $-534.26M | $-515.29M | -3.68% |
Net Income | $-519.02M | $-481.19M | -7.86% |
EPS (Basic) | $-5.25 | $-5.42 | +3.14% |
EPS (Diluted) | $-5.25 | $-5.42 | +3.14% |
R&D Expense | $466.31M | $435.07M | +7.18% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.19B | $1.3B | -8.45% |
Current Assets | $639.86M | $998.33M | -35.91% |
Total Liabilities | $319.06M | $250.81M | +27.21% |
Current Liabilities | $110.85M | $115.21M | -3.78% |
Stockholders' Equity | $871.96M | $1.05B | -16.97% |
Cash & Equivalents | $189.18M | $226.75M | -16.57% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-348.88M | $-394.09M | +11.47% |
Investing Cash Flow | $125.57M | $-31.35M | +500.57% |
Financing Cash Flow | $185.75M | $130.32M | +42.53% |
D&A | $10.29M | $8.98M | +14.58% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -923.1% | -1420.5% | +497.41% |
Net Margin | -896.8% | — | — |
ROE | -59.5% | — | — |
ROA | -43.6% | — | — |
Current Ratio | $5.772 | — | — |
Debt to Equity | $0.366 | — | — |
Other companies in Biotechnology